The largest database of trusted experimental protocols

Dneasy blood and tissue kit

Manufactured by Promega
Sourced in United States

The DNeasy Blood and Tissue Kit is a DNA extraction and purification product designed to isolate high-quality genomic DNA from a variety of sample types, including blood, tissues, and cultured cells. The kit utilizes a silica-based membrane technology to efficiently bind, wash, and elute DNA, providing a simple and effective method for DNA extraction.

Automatically generated - may contain errors

4 protocols using dneasy blood and tissue kit

1

Genetic Analysis of RHAG Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
For RHAG gene sequence analysis, DNA was extracted from donor PBMCs or hiPSCs by an automated method using the QIAsymphony instrument (Qiagen, Germany). Primers to amplify RHAG gene exon 6 are listed in Table S2. For CRISPR edit validation, genomic DNA was isolated from each expanded clone using DNeasy Blood and Tissue Kit (Promega). DNA regions encompassing guide sites were amplified using specific primers (Table S2). Amplification was performed with SequalPrep™ Long PCR Kit with dNTPs (Applied Biosystems, USA). The PCR products were Sanger sequenced using the Big Dye Terminator v1.1 kit (Applied Biosystems). Sequencing primers are also listed in Table S2. DNA sequences were aligned with the reference genomic sequences: NG_011704.1 for the RHAG gene and NG_006669.2 for ABO gene, using the CLC GenomicWorkbench 21.0.3 software (Qiagen).
+ Open protocol
+ Expand
2

DNA Extraction Using MolYsis Kit

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MolYsis Basic Kit was used according to the manufacturer’s instructions without modifications. MolYsis treatments required a separate extraction protocol, for which we used extraction by the Qiagen DNeasy Blood and Tissue kit or the Promega Wizard Genomic Purification Kit.
+ Open protocol
+ Expand
3

Comprehensive Tumor DNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Diagnostic biopsy specimens submitted to our institution were routinely examined in the course of intraoperative consultations (frozen sections), followed by standard formalin-fixation and paraffin-embedding (FFPE) for histological workup in most cases. External cases were either received as FFPE blocks or as near-native tumour tissue submitted in SurePath® (Becton Dickinson, USA) or ThinPrep® preservatives (Hologic Inc., USA). For cryopreserved biopsies, one to four 70 μm thick cryosections were collected. For FFPE blocks, a series of 8 or 14 serial sections (4 μm) were collected on glass slides, and an additional H&E section in the middle of each series was used to verify tumour cell content. In samples containing significant non-neoplastic or necrotic areas on the cut surface, viable tumour cell-rich areas were manually microdissected. For native specimens, DNA was extracted with automated commercial systems: Promega Maxwell® FFPE DNA extraction, Promega Maxwell® blood DNA extraction, and Qiagen DNeasy® Blood and Tissue kits on Maxwell or QiaCube® instruments (Promega, USA; Qiagen, Germany). DNA from FFPE specimens was extracted with the Promega Maxwell® FFPE DNA extraction, Qiagen DNeasy®, and RecoverAll® kits. Except for differences in average read lengths in nanopore sequencing runs for native materials, all of the above-mentioned kits produced technically valid results.
+ Open protocol
+ Expand
4

T7 Endonuclease Assay for Genome Editing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The T7 endonuclease assay was performed as described previously [21 (link), 22 (link)]. Briefly, genomic DNA was isolated using DNeasy Blood and Tissue kits (Promega, Madison, WI, USA) according to the manufacturer’s protocol. The region of DNA containing the nuclease target site was PCR-amplified using nested primers. Amplicons were denatured by heating and annealed to form heteroduplex DNA, which was then treated with 5 units of T7E1 (New England Biolabs, MA, USA) for 15 to 20 min at 37 °C, followed by 2% agarose gel electrophoresis. Mutation frequencies were calculated based on band intensity using ImageJ software and the following equation: mutation frequency (%) = 100 × (1 - [1 - fraction cleaved]1/2), where the fraction cleaved was the total relative density of the cleavage bands divided by the sum of the relative density of the cleaved and uncut bands. The oligonucleotide sequences used to obtain the PCR amplicons from the on-target genes for the T7E1 assay are listed in Supplementary Table S2. The oligonucleotide sequences used to obtain the PCR amplicons from the off-target genes for the T7E1 assay is previously described in [20 (link)]. The amplicon sizes of the USP3 and their expected cleavage sizes after the T7E1 assay are summarized in Supplementary Table S3.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!